SCHEMBL25922278

SCHEMBL25922278

CCC(CC)n1cnc2cc(Br)cc(C(F)(F)F)c21

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HCAR1 Q9BXC0 1/20 0.34
▸ ABL1 P00519 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31698360 0.87 ABL1 (0.39) HCAR1ABL1
SCHEMBL31698374 0.77 HCAR1 (0.38) HCAR1
SCHEMBL25922298 0.77 PRPS1 (0.41) HCAR1
SCHEMBL31698308 0.74 HCAR1 (0.34) HCAR1ABL1
SCHEMBL31698452 0.72 AR (0.41) HCAR1ABL1
SCHEMBL31349605 0.72 HCAR1 (0.33) HCAR1
SCHEMBL31698506 0.71 MEN1 (0.45) HCAR1
SCHEMBL31698068 0.69 ABL1 (0.37) ABL1
SCHEMBL11779175 0.67 PTGS2 (0.38) —
SCHEMBL31349425 0.67 HCAR1 (0.33) HCAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 — — WO disclosed
Send feedback